Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILON HEALTH, INC.

(AGL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Agilon health, inc. Names Karen Mcloughlin to its Board of Directors

07/12/2021 | 04:30pm EDT

agilon health, inc. has named Karen McLoughlin to its board of directors. McLoughlin is the former chief financial officer of Cognizant Technology Solutions, a Fortune 200 company and leading provider of information technology, business process and consulting services.


© S&P Capital IQ 2021
All news about AGILON HEALTH, INC.
09/15INSIDER SELL : Agilon Health
MT
09/10AGILON HEALTH : Cowen Starts agilon health at Outperform with $44 Price Target
MT
09/10AGILON HEALTH : Prices Secondary Share Offering At $30 Per Share
MT
09/09AGILON HEALTH : Announces Pricing of Secondary Offering
BU
09/07AGILON HEALTH : Stockholders to Offer 17 Million Common Shares in Secondary Offe..
MT
09/07AGILON HEALTH : Announces Secondary Offering
BU
09/05AGILON HEALTH : September 2021 Investor Presentation
PU
08/26AGILON HEALTH : to Participate in Upcoming Investor Conferences
BU
08/04AGILON HEALTH : Reports Second Quarter 2021 Results (Form 8-K)
PU
08/04AGILON : Q2 Earnings Snapshot
AQ
More news
Analyst Recommendations on AGILON HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 1 803 M - -
Net income 2021 -404 M - -
Net cash 2021 1 131 M - -
P/E ratio 2021 -28,7x
Yield 2021 -
Capitalization 11 340 M 11 340 M -
EV / Sales 2021 5,66x
EV / Sales 2022 4,12x
Nbr of Employees 550
Free-Float 98,5%
Chart AGILON HEALTH, INC.
Duration : Period :
agilon health, inc. Technical Analysis Chart | AGL | US00857U1079 | MarketScreener
Technical analysis trends AGILON HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 29,01 $
Average target price 42,86 $
Spread / Average Target 47,7%
EPS Revisions
Managers and Directors
Steven J. Sell President, Chief Executive Officer & Director
Timothy S. Bensley Chief Financial Officer
Ronald A. Williams Chairman
Benjamin Kornitzer Chief Medical & Quality Officer
Girish Venkatachaliah Chief Technology Officer
Sector and Competitors